AI Article Synopsis

  • Scientists studied a group of 70 overweight patients who had weight-loss surgery to see how their liver health changed over a year after the surgery.
  • They looked at special markers in their blood that could show if they had early signs of a liver disease called non-alcoholic fatty liver disease (NAFLD).
  • The results showed that after the surgery, the levels of harmful markers in their blood went down a lot, suggesting their liver health likely improved.

Article Abstract

Aim: Non-invasive tests for non-alcoholic fatty liver disease (NAFLD) are needed for assessing disease stage, prognosis and treatment efficacy. Extracellular matrix biomarkers, such as PRO-C3, are useful as biomarkers of advanced liver fibrosis. However, non-invasive biomarkers of early-stage NAFLD, characterized by pericellular fibrosis, are lacking. Here, we measured serological biomarkers of type IV and VIII collagens reflecting the remodeling of the pericellular basement membrane to explore the effect of bariatric surgery on pericellular fibrosis in patients with early NAFLD.

Methods: Seventy patients with severe obesity underwent bariatric surgery. The cohort consisted of 61 % females who had a mean age of 44. Patients had a median NAFLD activity score of 3 and mild-to-moderate fibrosis F0 (3 %), F1 (86 %), and F2 (11 %). Blood samples were taken at baseline, three, six and 12 months after surgery. At 12 months, 40 patients had a follow-up liver biopsy. The biomarkers PRO-C3, PRO-C4, C4M, and PRO-C8 were measured using indirect competitive ELISAs.

Results: Twelve months after surgery patients had significantly lower levels of ALT, GGT, HbA1c, fasting glucose, and CRP. The pericellular fibrosis biomarkers, C4M, PRO-C4, and PRO-C8 decreased by 24 %, 18 % and 44 %, respectively (p < 0.0001), while the interstitial matrix fibrosis marker PRO-C3 remained unchanged. Furthermore, baseline C4M was associated with histologically assessed hepatocyte ballooning and lobular inflammation in patients with (p = 0.032) and without (p = 0.032) steatosis, respectively.

Conclusion: Biomarkers of pericellular fibrosis decrease in early-stage NAFLD after patients undergo bariatric surgery and potentially reflect an improvement in liver histology.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2022.12.012DOI Listing

Publication Analysis

Top Keywords

pericellular fibrosis
16
bariatric surgery
12
non-alcoholic fatty
8
fatty liver
8
liver disease
8
biomarkers pro-c3
8
biomarkers
7
fibrosis
6
pericellular
5
liver
5

Similar Publications

Objectives: Giant cell hepatitis is an important diagnostic consideration in early childhood, especially for patients who present with jaundice. Different diseases may play a role in their etiology. In this study, we presented pediatric patients in our center diagnosed with giant cell hepatitis.

View Article and Find Full Text PDF
Article Synopsis
  • - Liver disease is a significant risk factor for higher mortality in patients with common variable immunodeficiency (CVID), mainly due to conditions like presinusoidal portal hypertension (PHTN) from nodular regenerative hyperplasia (NRH).
  • - Recent studies have explored the causes and treatment options, revealing that T-cell damage leads to NRH and PHTN in CVID patients, with elevated liver stiffness and enlarged spleens as potential red flags for early detection.
  • - There is a call for more research to improve the understanding of liver diseases in CVID and to establish effective treatment protocols, as current strategies are often inconsistent and based on trial and error.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists created a new mouse model to study alcohol-associated hepatitis (AAH) that is more similar to humans than older models.
  • They fed male mice a special diet containing alcohol and a chemical called thioacetamide for 12 weeks to induce liver damage.
  • The results showed that these mice had major signs of liver problems, inflammation, and changes in gut bacteria, making it a better tool to study AAH compared to other methods.
View Article and Find Full Text PDF

The roles of hyaluronan in kidney development, physiology and disease.

Nat Rev Nephrol

December 2024

Department of Internal Medicine (Nephrology) & Einthoven Laboratory of Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.

The hyaluronan (HA) matrix in the tissue microenvironment is crucial for maintaining homeostasis by regulating inflammatory signalling, endothelial-mesenchymal transition and cell migration. During development, covalent modifications and osmotic swelling of HA create mechanical forces that initiate midgut rotation, vascular patterning and branching morphogenesis. Together with its main cell surface receptor, CD44, HA establishes a physicochemical scaffold at the cell surface that facilitates the interaction and clustering of growth factors and receptors that is required for normal physiology.

View Article and Find Full Text PDF

NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review.

Int J Mol Sci

August 2024

Department of Laboratory Medicine, University of Alberta, Edmonton, AB T6G 2B7, Canada.

Nonalcoholic fatty liver disease (NAFLD), or metabolic dysfunction-associated steatotic liver disease (MASLD), is a liver condition that is linked to overweight, obesity, diabetes mellitus, and metabolic syndrome. Nonalcoholic steatohepatitis (NASH), or metabolic dysfunction-associated steatohepatitis (MASH), is a form of NAFLD/MASLD that progresses over time. While steatosis is a prominent histological characteristic and recognizable grossly and microscopically, liver biopsies of individuals with NASH/MASH may exhibit several other abnormalities, such as mononuclear inflammation in the portal and lobular regions, hepatocellular damage characterized by ballooning and programmed cell death (apoptosis), misfolded hepatocytic protein inclusions (Mallory-Denk bodies, MDBs), megamitochondria as hyaline inclusions, and fibrosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!